Abstract:Gadolinium-based magnetic resonance imaging (MRI) contrast agents with biodegradability, biosafety, and high efficiency are highly desirable for tumor diagnosis. Herein, a biodegradable, AS1411-conjugated, α-cyclodextrin polyrotaxane-based MRI contrast agent (AS1411-G2(DTPA-Gd)-SS-PR) was developed for targeted imaging of cancer. The polyrotaxane-based contrast agent was achieved by the complexation of α-cyclodextrin (α-CD) and a linear poly(ethylene glycol) (PEG) chain containing disulfide linkages at two terminals. The disulfides enable the dethreading of the polyrotaxane into excretable small units due to cleavage of the disulfide linkages by reducing agents such as intracellular glutathione (GSH). Furthermore, the second-generation lysine dendron conjugated with gadolinium chelates and AS1411, a G-quadruplex oligonucleotide that has high binding affinity to nucleolin generally presenting a high level on the surface of tumor cells, coupled to the α-CD via click chemistry. The longitudinal relaxivity of AS1411-G2(DTPA-Gd)-SS-PR (11.7 mM-1 s-1) was two times higher than the clinically used Gd-DTPA (4.16 mM-1 s-1) at 0.5 T. The in vitro degradability was confirmed by incubating with 10 mM 1,4-dithiothreitol (DTT). Additionally, the cytotoxicity, histological assessment, and gadolinium retention studies showed that the prepared polyrotaxane-based contrast agent had a superior biocompatibility and was predominantly cleared renally without long-term accumulation toxicity. Importantly, AS1411-G2(DTPA-Gd)-SS-PR displayed the enhanced performance in MRI of breast cancer cells in vitro as well as a subcutaneous breast tumor in vivo due to the targeting ability of the AS1411 aptamer. The enhanced performance was due to efficient multivalent interactions with tumor cells, producing faster accumulation and longer contrast imaging time at the tumor site. This work clearly confirms that the specially designed and fabricated α-CD-based polyrotaxane is a promising contrast agent with an excellent contrast imaging performance and biosafety for tumor MR imaging.

Gd3+-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic-2-hydroxypropyl-β-cyclodextrin/Pluronic Polyrotaxane As a Long Circulating High Relaxivity MRI Contrast Agent

Synthesis of Magnetic Resonance Imaging Contrast Agent with Tethered Quaternary Ammonium Group

Gadolinium Complexes of Macrocyclic Diethylenetriamine-N-oxide Pentaacetic Acid-Bisamide As Highly Stable MRI Contrast Agents with High Relaxivity.

PEGylated Amphiphilic Gd-DOTA Backboned-Bound Branched Polymers As Magnetic Resonance Imaging Contrast Agents.

HP-DO3A-based Amphiphilic MRI Contrast Agents and Relaxation Enhancement Through Their Assembly with Polyelectrolytes.

Gadolinium-based Contrast Agents Built of DO3A-pyridine Scaffold: Precisely Tuning Carboxylate Group for Enhanced Magnetic Resonance Imaging

High Relaxivity Trimetallic Nitride (gd3n) Metallofullerene Mri Contrast Agents with Optimized Functionality

A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent

Preparation of Mn2+@PolyDOPA-b-polysarcosine Micelle As MRI Contrast Agent with High Longitudinal Relaxivity

Facile Preparation of a New Gadofullerene-Based Magnetic Resonance Imaging Contrast Agent with High 1H Relaxivity

An MRI contrast agent based on a zwitterionic metal-chelating polymer for hepatorenal angiography and tumor imaging.

Gadolinium-conjugated Star-Block Copolymer Polylysine-Modified Polyethylenimine As High-Performance T1 MR Imaging Blood Pool Contrast Agents

Development of an Aptamer-Conjugated Polyrotaxane-Based Biodegradable Magnetic Resonance Contrast Agent for Tumor-Targeted Imaging.

Gadolinium(III) Complex-Backboned Branched Polymers As Imaging Probes for Contrast-Enhanced Magnetic Resonance Angiography

Maximizing the Relaxivity of Gd-Complex by Synergistic Effect of Hsa and Carboxylfullerene

Self‐Assembling Peptide‐Based High‐Relaxivity Targeted MRI Contrast Agents

Reductive Microenvironment Responsive Gadolinium-Based Polymers As Potential Safe MRI Contrast Agents

Ultrasmall gadolinium hydrated carbonate nanoparticle: An advanced T 1 MRI contrast agent with large longitudinal relaxivity

Relaxivity Modulation of Gd-HPDO3A-like Complexes by Introducing Polar and Protic Peripheral Groups

The gadolinium complexes with polyoxometalates as potential MRI contrast agents.

Safe and Potent MRI Contrast Agents by Complexing Gadolinium with Enzyme/reduction Dual-Sensitive Branched Polymers